List of Cara Therapeutics patents

Patents where

Current Assignee

Name

Cara Therapeutics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7402564 Synthetic peptide amides	Patent 7402564 was granted and assigned to Cara Therapeutics on July, 2008 by the United States Patent and Trademark Office.		Cara Therapeutics	United States Patent and Trademark Office	7402564	July 22, 2008
‌ US Patent 7741350 Bicyclic pyrazolo-heterocycles	Patent 7741350 was granted and assigned to Cara Therapeutics on June, 2010 by the United States Patent and Trademark Office.		Cara Therapeutics	United States Patent and Trademark Office	7741350	June 22, 2010
‌ US Patent 9334305 Synthetic peptide amides and dimers thereof	Patent 9334305 was granted and assigned to Cara Therapeutics on May, 2016 by the United States Patent and Trademark Office.	Cara Therapeutics	Cara Therapeutics	United States Patent and Trademark Office	9334305	May 10, 2016
‌ US Patent 8431565 Substituted imidazoheterocycles	Patent 8431565 was granted and assigned to Cara Therapeutics on April, 2013 by the United States Patent and Trademark Office.		Cara Therapeutics	United States Patent and Trademark Office	8431565	April 30, 2013
‌ US Patent 8951970 Synthetic peptide amides for pain	Patent 8951970 was granted and assigned to Cara Therapeutics on February, 2015 by the United States Patent and Trademark Office.		Cara Therapeutics	United States Patent and Trademark Office	8951970	February 10, 2015
‌ US Patent 8217007 Synthetic peptide amides	Patent 8217007 was granted and assigned to Cara Therapeutics on July, 2012 by the United States Patent and Trademark Office.		Cara Therapeutics	United States Patent and Trademark Office	8217007	July 10, 2012
‌ US Patent 8835422 Substituted imidazoheterocycle derivatives	Patent 8835422 was granted and assigned to Cara Therapeutics on September, 2014 by the United States Patent and Trademark Office.		Cara Therapeutics	United States Patent and Trademark Office	8835422	September 16, 2014
‌ US Patent 7517874 Substituted imidazo[1,5-a][1,4]diazepines and imidazo[1,5-a]pyrazines as cannabinoid receptor agonists for the treatment of pain	Patent 7517874 was granted and assigned to Cara Therapeutics on April, 2009 by the United States Patent and Trademark Office.		Cara Therapeutics	United States Patent and Trademark Office	7517874	April 14, 2009
‌ US Patent 7727963 Synthetic peptide amides	Patent 7727963 was granted and assigned to Cara Therapeutics on June, 2010 by the United States Patent and Trademark Office.		Cara Therapeutics	United States Patent and Trademark Office	7727963	June 1, 2010
‌ US Patent 7960376 Benzo-fused heterocycles	Patent 7960376 was granted and assigned to Cara Therapeutics on June, 2011 by the United States Patent and Trademark Office.		Cara Therapeutics	United States Patent and Trademark Office	7960376	June 14, 2011
‌ US Patent 8669079 Methods for genetic analysis of textiles made of	Patent 8669079 was granted and assigned to Cara Therapeutics on March, 2014 by the United States Patent and Trademark Office.		Cara Therapeutics	United States Patent and Trademark Office	8669079	March 11, 2014
‌ US Patent 8217000 Method for elevating prolactin in mammals	Patent 8217000 was granted and assigned to Cara Therapeutics on July, 2012 by the United States Patent and Trademark Office.		Cara Therapeutics	United States Patent and Trademark Office	8217000	July 10, 2012
‌ US Patent 7960377 Substituted pyridoxazines	Patent 7960377 was granted and assigned to Cara Therapeutics on June, 2011 by the United States Patent and Trademark Office.		Cara Therapeutics	United States Patent and Trademark Office	7960377	June 14, 2011
‌ US Patent 9359399 Synthetic peptide amides	Patent 9359399 was granted and assigned to Cara Therapeutics on June, 2016 by the United States Patent and Trademark Office.	Cara Therapeutics	Cara Therapeutics	United States Patent and Trademark Office	9359399	June 7, 2016
‌ US Patent 9321810 Uses of kappa opioid synthetic peptide amides	Patent 9321810 was granted and assigned to Cara Therapeutics on April, 2016 by the United States Patent and Trademark Office.	Cara Therapeutics	Cara Therapeutics	United States Patent and Trademark Office	9321810	April 26, 2016
‌ US Patent 8211926 Bicyclic pyrazolo-heterocycles	Patent 8211926 was granted and assigned to Cara Therapeutics on July, 2012 by the United States Patent and Trademark Office.		Cara Therapeutics	United States Patent and Trademark Office	8211926	July 3, 2012
‌ US Patent 8653127 Bicyclic pyrazolo-heterocycles	Patent 8653127 was granted and assigned to Cara Therapeutics on February, 2014 by the United States Patent and Trademark Office.		Cara Therapeutics	United States Patent and Trademark Office	8653127	February 18, 2014
‌ US Patent 7713937 Synthetic peptide amides and dimeric forms thereof	Patent 7713937 was granted and assigned to Cara Therapeutics on May, 2010 by the United States Patent and Trademark Office.		Cara Therapeutics	United States Patent and Trademark Office	7713937	May 11, 2010
‌ US Patent 7842662 Synthetic peptide amide dimers	Patent 7842662 was granted and assigned to Cara Therapeutics on November, 2010 by the United States Patent and Trademark Office.		Cara Therapeutics	United States Patent and Trademark Office	7842662	November 30, 2010
‌ US Patent 8236766 Uses of synthetic peptide amides	Patent 8236766 was granted and assigned to Cara Therapeutics on August, 2012 by the United States Patent and Trademark Office.		Cara Therapeutics	United States Patent and Trademark Office	8236766	August 7, 2012
‌ US Patent 8486894 Synthetic peptide amides and dimeric forms thereof	Patent 8486894 was granted and assigned to Cara Therapeutics on July, 2013 by the United States Patent and Trademark Office.		Cara Therapeutics	United States Patent and Trademark Office	8486894	July 16, 2013
‌ US Patent 8859538 Uses of substituted imidazoheterocycles	Patent 8859538 was granted and assigned to Cara Therapeutics on October, 2014 by the United States Patent and Trademark Office.		Cara Therapeutics	United States Patent and Trademark Office	8859538	October 14, 2014
‌ US Patent 8536131 Synthetic peptide amides and dimers thereof	Patent 8536131 was granted and assigned to Cara Therapeutics on September, 2013 by the United States Patent and Trademark Office.		Cara Therapeutics	United States Patent and Trademark Office	8536131	September 17, 2013
‌ US Patent 11986509 Oligosaccharide formulations of kappa opioid receptor agonists	Patent 11986509 was granted and assigned to Cara Therapeutics on May, 2024 by the United States Patent and Trademark Office.	Cara Therapeutics	Cara Therapeutics	United States Patent and Trademark Office	11986509	May 21, 2024
‌ US Patent 11684674 Oral formulations of kappa opioid receptor agonists		Cara Therapeutics	Cara Therapeutics	United States Patent and Trademark Office	11684674	June 27, 2023

Results per page:

25 results

0 selected

25 results

0 selected